Clin2
NCT07370389Possibly a fitRecruiting

Testing a new pain drug for shingles pain

Herpes ZosterPain

Treatments studied

Part of Infections, Pain clinical trials.

This trial tests a new pain medication called tulodesvenlafaxine for people with shingles-related pain. It may help if you have moderate to severe pain that started within the last 90 days.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
750 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • Your shingles rash must have started within the last 90 days.
  • You must have moderate to severe shingles pain (score of 4 or more on a 0–10 pain scale).
  • Your liver and kidney function must be within acceptable limits (checked by blood tests).
  • You should not have other ongoing pain conditions or serious illnesses like immune disorders, organ transplant, or cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07361809Recruiting
Desvenlafaxine for shingles pain relief

This trial tests if desvenlafaxine (an antidepressant also used for nerve pain) can safely reduce pain from shingles. It may be an option if your shingles pain is moderate to severe and started within the last 3 months.

Beijing
NCT07307976Recruiting
Testing a new pain drug for shingles pain

This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.

Beijing
NCT07361796Recruiting
Venlafaxine to prevent nerve pain after shingles

This trial tests whether the drug venlafaxine, usually used for depression, can help prevent long-term nerve pain (postherpetic neuralgia) after a shingles infection. If you are currently experiencing shingles pain, joining this study might reduce your chances of developing chronic pain later.

Beijing
NCT07370402Recruiting
Flurbiprofen patch for shingles pain relief

This trial tests if a flurbiprofen skin patch can reduce pain from shingles (herpes zoster). It may help people with moderate to severe pain who have had the rash for less than 90 days.

Beijing
NCT07378059Recruiting
Loxoprofen patch for shingles pain

This trial tests if a loxoprofen skin patch (a non-steroidal anti-inflammatory drug) can safely relieve moderate to severe pain from shingles. It may be an option for people who have had shingles rash for less than 90 days.

Beijing
NCT06914206Not yet recruiting
Esketamine added to nerve block for recent shingles pain

This study tests whether adding a medicine called esketamine to a standard nerve block procedure can improve pain relief for people with shingles-related nerve pain. If you have had shingles pain for less than 3 months, this might help reduce pain and prevent long-term discomfort.

Beijing, Beijing Municipality

Hear when a new Herpes Zoster trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.